[Quality of care and safety indicators in anticoagulated patients with non-valvular auricular fibrillation and deep venous thromboembolic disease]

J Healthc Qual Res. 2018 Mar-Apr;33(2):68-74. doi: 10.1016/j.cali.2017.12.009. Epub 2018 Mar 19.
[Article in Spanish]

Abstract

Objectives: To identify and prioritise indicators to assess the quality of care and safety of patients with non-valvular auricular fibrillation (NVAF) and deep vein thrombosis (DVT) treated with anticoagulants.

Materials and methods: Using the consensus conference technique, a group of professionals and clinical experts, the determining factors of the NVAF and DVT care process were identified, in order to define the quality and safety criteria. A proposal was made for indicators of quality and safety that were prioritised, taking into account a series of pre-established attributes. The selected indicators were classified into indicators of context, safety, action, and outcomes of the intervention in the patient.

Results: A set of 114 health care and safety quality indicators were identified, of which 35 were prioritised: 15 for NVAF and 20 for DVT. About half (49%) of the indicators (40% for NVAF and 55% for DVT) applied to patient safety, and 26% (33% for NVAF and 20% for DVT) to the outcomes of interventions in the patient.

Conclusions: The present work presents a set of agreed indicators by a group of expert professionals that can contribute to the improvement of the quality of care of patients with NVAF and DVT treated with anticoagulants.

Keywords: Atrial fibrillation; Calidad asistencial; Deep vein thrombosis; Fibrilación auricular; Health care quality; Pulmonary thromboembolism; Tromboembolia pulmonar; Trombosis venosa profunda.

Publication types

  • Consensus Development Conference

MeSH terms

  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Antithrombins / administration & dosage
  • Atrial Fibrillation / complications*
  • Atrial Fibrillation / therapy
  • Benchmarking
  • Electric Countershock / adverse effects
  • Humans
  • Patient Safety*
  • Quality Indicators, Health Care / classification*
  • Quality Indicators, Health Care / statistics & numerical data
  • Venous Thrombosis / etiology
  • Venous Thrombosis / prevention & control*

Substances

  • Anticoagulants
  • Antithrombins